Quality and validation support for advanced therapy developers transitioning to commercial biologics manufacturing, where complex, patient-specific processes and evolving FDA guidance raise the bar.
Quality and validation expertise calibrated to the demands of cell and gene therapy production.
Quality systems that support the traceability demands of autologous and allogeneic therapies, including chain-of-custody validation.
Working to current FDA guidance on advanced therapy medicinal products (ATMPs).
Validation and quality system support as programs move from clinical to commercial manufacturing.
A biotech company transitioning from clinical to commercial manufacturing needs a validation lead and quality systems consultant experienced in biologics GMP production environments.
A biotech preparing for its first FDA pre-approval inspection needs contract compliance and CSV support, including mock inspections, documentation review, and validated systems and electronic records that meet Part 11 and Annex 11 requirements before the inspection window.
Tell us about your organization, regulatory environment, and need. We will scope the engagement against your specific GxP context.